참고문헌
- Ali, N. and A. Siddiqui. 1995. Interaction of polypyrimidine tractbinding protein with the 5' noncoding region of the hepatitis C virus RNA genome and its functional requirement in internal initiation of translation. J. Virol. 69, 6367-6375
- Anwar, A., N. Ali, R. Tanveer, and A. Siddiqui. 2000. Demonstration of functional requirement of polypyrimidine tract-binding protein by SELEX RNA during hepatitis C virus internal ribosome entry site-mediated translation initiation. J. Biol. Chem. 275, 34231-34235 https://doi.org/10.1074/jbc.M006343200
- Araki, M., Y. Okuno, Y. Hara, and Y. Sugiura. 1998. Allosteric regulation of a ribozyme activity through ligand-induced conformational change. Nucleic Acids Res. 26, 3379-3384 https://doi.org/10.1093/nar/26.14.3379
- Biroccio, A., J. Hamm, I. Incitti, R. De Francesco, and L. Tomei. 2002. Selection of RNA aptamers that are specific and high-affinity ligands of the hepatitis C virus RNA-dependent RNA polymerase. J. Virol. 76, 3688-3696 https://doi.org/10.1128/JVI.76.8.3688-3696.2002
- Chevalier, C., A. Saulnier, Y. Benureau, D. Flechet, D. Delgrange, F. Colbere-Garapin, C. Wychowski, and A. Martin. 2007. Inhibition of hepatitis C virus infection in cell culture by small interfering RNAs. Mol. Ther. 15, 1452-1462 https://doi.org/10.1038/sj.mt.6300186
- Choo, Q.L., G. Kuo, A.J. Weiner, L.R. Overby, D.W. Bradley, and M. Houghton. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359-362 https://doi.org/10.1126/science.2523562
- Hahm, B., D.S. Han, S.H. Back, O.K. Song, M.J. Cho, C.J. Kim, K. Shimotohno, and S.K. Jang. NS3-4A of hepatitis C virus is a chymotrypsin-like protease. 1995. J. Virol. 69, 2534-2539
- Hermann, T. and D.J. Patel. 2000. Adaptive recognition by nucleic acid aptamers. Science 287, 820-825 https://doi.org/10.1126/science.287.5454.820
- Hino, K., S. Sainokami, K. Shimoda, S. Iino, Y. Wang, H. Okamoto, Y. Miyakawa, and M. Mayumi. 1994. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J. Med. Virol. 42, 299-305 https://doi.org/10.1002/jmv.1890420318
- Hwang, B., J.S. Cho, H.J. Yeo, J.H. Kim, K.M. Chung, K. Han, S.K. Jang, and S.W. Lee. 2004. Isolation of specific and high-affinity RNA aptamers against NS3 helicase domain of hepatitis C virus. RNA 10, 1277-1290 https://doi.org/10.1261/rna.7100904
- Jenison, R.D., S.C. Gill, A. Pardi, and B. Polisky. 1994. High-resolution molecular discrimination by RNA. Science 263, 1425-1429 https://doi.org/10.1126/science.7510417
- Kapadia, S.B., A. Brideau-Andersen, and F.V. Chisari. 2003. Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc. Natl. Acad. Sci. USA 100, 2014-2018
- Kertsburg, A. and G.A. Soukup. 2002. A versitile communication module for controlling RNA folding and catalysis. Nucleic Acids Res. 30, 4599-4606 https://doi.org/10.1093/nar/gkf596
- Kolykhalov, A.A., K. Mihalik, S.M. Feinstone, and C.M. Rice. 2000. Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo. J. Virol. 74, 2046-2051 https://doi.org/10.1128/JVI.74.4.2046-2051.2000
- Kuo, G., Q.L. Choo, H.J. Alter, G.L. Gitnick, A.G. Redeker, R.H. Purcell, T. Miyamura, J.L. Dienstag, M.J. Alter, and C.E. Stevens. 1989. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244, 362-364 https://doi.org/10.1126/science.2496467
- Macejak, D.G., K.L. Jensen, S.F. Jamison, K. Domenico, E.C. Roberts, N. Chaudhary, I. Von Carlowitz, L. Bellon, M.J. Tong, A. Conrad, P.A. Pavco, and L.M. Blatt. 2000. Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes. Hepatology 31, 769-776 https://doi.org/10.1002/hep.510310331
- Pagliaro, L., A. Craxi, C. Cammaa, F. Tine, V. Di Marco, L. Iacono, and P. Almasio. 1994. Interferon-alpha for chronic hepatitis C: an analysis of pretreatment clinical predictors of response. Hepatology 19, 820-828
- Penchovsky, R. and R.R. Breaker. 2005. Computational design and experimental validation of oligonucleotide-sensing allosteric ribozymes. Nat. Biotechnol. 23, 1424-1433 https://doi.org/10.1038/nbt1155
- Penin, F., J. Dubuisson, F.A. Rey, D. Moradpour, and J.M. Pawlotsky. 2004. Structural biology of hepatitis C virus. Hepatology 39, 5-19 https://doi.org/10.1002/hep.20032
- Pley, H.W., K.M. Flaherty, and D.B. McKay. 1994. model for an RNA tertiary interaction from the structure of an intermolecular complex between a GAAA tetraloop and an RNA helix. Nature 372, 111-113 https://doi.org/10.1038/372111a0
- Ryu, K.J., J.H. Kim, and S.W. Lee. 2003. Ribozyme-mediated selective induction of new gene activity in hepatitis C virus internal ribosome entry site-expressing cells by targeted trans-splicing. Mol. Ther. 7, 386-395 https://doi.org/10.1016/S1525-0016(02)00063-1
- Ryu, K.J. and S.W. Lee. 2004. Comparative analysis of intracellular trans-splicing ribozyme activity against hepatitis C virus internal ribosome entry site. J. Microbiol. 42, 361-364
- Saito, I., T. Miyamura, A. Ohbayashi, H. Harada, T. Katayama, S. Kikuchi, Y. Watanabe, S. Koi, M. Onji, Y. Ohta, Q. Choo, M. Houghton, and G. Kuo. 1990. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl Acad. Sci. USA 87, 6547-6549